Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...
Vous n'êtes pas connecté
WEDNESDAY, Sept. 18, 2024 -- Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b resectable nasal and paranasal sinus squamous cell carcinoma (NPNSCC) requiring orbital or skull...
Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...
Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...
New data from landmark analysis presented today report a decreased risk of disease recurrence or death in patients with resectable NSCLC who received...
THURSDAY, Sept. 12, 2024 -- For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free...
Highlights: Chemotherapy before surgery increases organ preservation from 15% to 50% The trial provides a new tr
A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...
A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...
FRIDAY, Sept. 6, 2024 -- Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with...
THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...
THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...